- +1-315-215-1633
- sales@thebrainyinsights.com
The global therapeutic drug monitoring market is expected to grow from USD 2 billion in 2022 to USD 5.18 billion by 2032, at a CAGR of 10% from 2023-2032. The increasing incidence of chronic diseases will augment the growth of the global therapeutic drug monitoring market.
Therapeutic drugs offer comfort and heal a variety of illnesses. They are also used in recovery or post-op. Therapeutic drugs can be purchased over the counter. However, some drugs are subject to governmental regulation or close observation by medical specialists. Monitoring and control are necessary as the wrong dosage can be ineffective or cause several side effects. Therapeutic drug monitoring refers to this close monitoring, analysis and control of drugs in the body to keep their effectiveness optimal and not cause harm to the patient. The sample is collected and analyzed in a clinical laboratory setting. A physician interprets the results or parameters of the tests, and the treatment is devised on this basis. For instance, the physician continues with the exact dosage if the results are within a prescribed therapeutic index. The dosage range at which a medicine is effective without causing unacceptably serious side effects is known as the therapeutic index. This method is utilized to prescribe treatment plans for precision treatments for conditions which show varied versions like cancer or autoimmune diseases. Immunoassay and chromatographic techniques are some therapeutic drug monitoring methods. The analytical requirements of sensitivity, precision, and accuracy required for most TDM applications are addressed by the immunochemical and chromatographic approaches. TDM offers valuable insight into the potential causes of treatment failure and enables a better management strategy.
Get an overview of this study by requesting a free sample
March 2023 – Chimeric antigen receptor T (CAR-T) cell treatment has significantly advanced over the past ten years. The FDA's approval of CAR-T therapy and increased productive clinical trials have demonstrated how drastically it is changing cancer treatment. Six CAR-T cell treatments for leukaemia, lymphomas, and multiple myeloma have received FDA approval to treat blood malignancies. All immunotherapies have ongoing studies and pipelines, but CAR-T has the most, with 857 trials and 1,432 pipelines worldwide, demonstrating that it is still the most active and promising immunotherapy.
The increasing demand for organ transplants – Given the lifestyle and environmental changes, the rising incidence and prevalence of several acute and chronic diseases will drive the demand for healthcare services. The incidence of cardiovascular, pulmonary, kidney and liver diseases has grown given the rise in alcohol consumption, smoking, bad diet and sedentary lifestyle with no physical exercise. Most patients are able to resolve these health problems with drugs, medication or minor surgical procedures. However, sometimes the last resort is an organ transplant, or it can be the best and optimal treatment plan for a patient. The kidney, liver, heart and lungs are the most transplanted organs globally. Rising stress levels and the diabetic population have increased the number of individuals suffering from kidney failures. Similarly, excessive alcohol consumption and substance abuse have led to liver failure in a significant portion of the population. Kidney and liver transplants are highly popular treatment options among patients. The increasing demand for organ transplants will drive the global therapeutic drug monitoring market. A successful organ transplant operation will require the right dosage/amount of immunosuppressants to make the recipient's body accept the organ. The adequate and effective medication dosage to ensure organ acceptance without causing severe side effects is achieved by therapeutic drug monitoring methods.
The high initial cost of investment – The fresh samples are collected from patents and transferred to laboratories for testing and analysis. The laboratories utilize several techniques to establish the concentration of drugs in the bloodstream and their effectiveness. The setup for testing and analysis, storage and transfer of samples, and proper collection involve significant resources. These resources have high investment costs. Given the significant initial investments and high recurring costs, several hospitals do not offer these services. Therefore, the high investment costs will hamper the market's growth.
The increasing research and development – The increasing incidence and prevalence of autoimmune diseases and other chronic diseases have increased the demand for precision medication treatment plans. Customized medication plans are effective and offer higher patient outcomes. Therapeutic drug monitoring enables physicians to develop the optimal medication plan to effectively target diseases/conditions without causing adverse side effects. It also enables them to monitor the treatment progress and adjust it accordingly. However, there are several limitations to therapeutic drug monitoring methods. These methods are not 100% accurate or reliable. These results can alter treatment plans and cause undesirable effects. Therefore, the market players are developing better testing methods, compatible medications and reliable systems. Significant capital is also being invested in developing the necessary infrastructure for therapeutic drug monitoring. Positive reimbursement policies are being expanded to offer precision medicine to more patients. All these factors will offer lucrative opportunities in the global therapeutic drug monitoring market in the forecast period.
The presence of simpler alternatives – Several techniques exist to establish the drug efficacy other than therapeutic drug monitoring. The requirement to collect fresh samples at regular intervals causes inconvenience for patients as well as physicians. Furthermore, the sensitive assays can lead to a diversion in results which causes miscalculations while arriving at drug efficacy. The presence of other simpler and more convenient alternatives to establish drug efficacy will challenge the market's growth.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global therapeutic drug monitoring market, with a 43% market revenue share in 2022. The region is witnessing an increase in the incidence of autoimmune, cardiovascular, pulmonary and other chronic diseases, given the lifestyle changes in the population associated with high-stress levels, bad diet and no physical exercise. The well-established healthcare infrastructure enables patients to access precision treatment. Significant market players facilitate greater innovation in the therapeutic drug monitoring industry, which augments the market’s development. The increasing fiscal investment in research and development in the pharmaceutical and biotechnology industries will also bode well for the market. The wide coverage of healthcare services and favourable reimbursement policies also contribute to the region's growth in the global market.
North America Region Therapeutic Drug Monitoring Market Share in 2022 - 43%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The product type segment is divided into equipment, consumables and others. The consumables segment dominated the market with a market share of around 54% in 2022. Consumables are products and equipment used more frequently with every test or group. They are used and thrown out afterwards. Syringes, beakers, funnels, test tubes, gloves, and liquids or dyes used for testing and analysis are some consumables used daily. These are used more frequently than long-lasting equipment. The rate of their consumption, given their significant rate of disposition, contributes to its dominance in the global therapeutic drug monitoring market.
The technology is divided into spectrometry, electrophoresis, chromatography, proteomic technology, immunoassays and others. The immunoassays segment dominated the market with a market share of around 40% in 2022. An immunoassay is a testing method to establish the presence and concentration of drugs or certain molecules in a solution. Immunoassays are extensively used in drug development and discovery of drug analysis. It is also used in diagnostics and therapeutic drug monitoring. There are several types of immunoassays. Enzyme immunoassays (EIA), fluoro-immunoassays (FIA), radioimmunoassays (RIA), and chemiluminescent immunoassays (CLIA) are a few common examples. Given their high sensitivity and detection capabilities, immunoassays offer a quick, easy, and cost-effective drug monitoring method.
The drug class is divided into antibiotics, antiarrhythmic, bronchodilators, HIV/AIDS drugs, antineoplastics, immunosuppressive, antiepileptic and others. The antiepileptic segment dominated the market with a market share of around 39% in 2022. Antiepileptic drugs help in preventing seizures or convulsions. These drugs regulate the brain's electrical activity to control seizure activity. Antiepileptic drugs are used to treat seizure disorders like epilepsy. They specifically influence ion (sodium, potassium, calcium, and chloride) channels in the cell membrane. The ions are responsible for electrical activity, and controlling them helps reduce seizures. Topiramate, lamotrigine, carbamazepine, sodium valproate, and levetiracetam are antiepileptic drugs. They are used in treating migraine, and neuropathic pain, among other conditions.
The end user is divided into hospitals, research and academic institutes, diagnostic labs and others. The hospital segment dominated the market with a market share of around 41% in 2022. Hospitals have the necessary infrastructure, equipment, consumables and professionals to perform therapeutic drug monitoring. Furthermore, most patients requiring therapeutic drug monitoring are admitted to hospitals, facilitating the segment's market dominance. The increasing fiscal expenditure on developing healthcare infrastructure will benefit the segment's growth.
Report Description:
| Attribute | Description |
|---|---|
| Market Size | Revenue (USD Billion) |
| Market size value in 2022 | USD 2 Billion |
| Market size value in 2032 | USD 5.18 Billion |
| CAGR (2023 to 2032) | 10% |
| Historical data | 2019-2021 |
| Base Year | 2022 |
| Forecast | 2023-2032 |
| Regional Segments | The regions examined for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa. |
| Segments | The research segment is based on product type, technology, drug class and end user. |
As per The Brainy Insights, the size of the global therapeutic drug monitoring market was valued at USD 2 billion in 2022 to USD 5.18 billion by 2032.
Global therapeutic drug monitoring market is growing at a CAGR of 10% during the forecast period 2023-2032.
The market's growth will be influenced by the increasing demand for organ transplants.
The high initial cost of investment could hamper the market growth.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by Product Type
4.3.2. Market Attractiveness Analysis by Technology
4.3.3. Market Attractiveness Analysis by Drug Class
4.3.4. Market Attractiveness Analysis by End User
4.3.5. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. The increasing demand for organ transplants
5.3. Restraints
5.3.1. The high initial cost of investment
5.4. Opportunities
5.4.1. The increasing research and development
5.5. Challenges
5.5.1. The presence of simpler alternatives
6. Global Therapeutic Drug Monitoring Market Analysis and Forecast, By Product Type
6.1. Segment Overview
6.2. Equipment
6.3. Consumables
6.4. Others
7. Global Therapeutic Drug Monitoring Market Analysis and Forecast, By Technology
7.1. Segment Overview
7.2. Spectrometry
7.3. Electrophoresis
7.4. Chromatography
7.5. Proteomic Technology
7.6. Immunoassays
7.7. Others
8. Global Therapeutic Drug Monitoring Market Analysis and Forecast, By Drug Class
8.1. Segment Overview
8.2. Antibiotics
8.3. Antiarrhythmic
8.4. Bronchodilators
8.5. HIV/AIDS Drugs
8.6. Antineoplastics
8.7. Immunosuppressive
8.8. Antiepileptic
8.9. Others
9. Global Therapeutic Drug Monitoring Market Analysis and Forecast, By End User
9.1. Segment Overview
9.2. Hospitals
9.3. Research and Academic Institutes
9.4. Diagnostic Labs
9.5. Others
10. Global Therapeutic Drug Monitoring Market Analysis and Forecast, By Regional Analysis
10.1. Segment Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.5. South America
10.5.1. Brazil
10.6. Middle East and Africa
10.6.1. UAE
10.6.2. South Africa
11. Global Therapeutic Drug Monitoring Market-Competitive Landscape
11.1. Overview
11.2. Market Share of Key Players in the Therapeutic Drug Monitoring Market
11.2.1. Global Company Market Share
11.2.2. North America Company Market Share
11.2.3. Europe Company Market Share
11.2.4. APAC Company Market Share
11.3. Competitive Situations and Trends
11.3.1. Product Launches and Developments
11.3.2. Partnerships, Collaborations, and Agreements
11.3.3. Mergers & Acquisitions
11.3.4. Expansions
12. Company Profiles
12.1. Abbott
12.1.1. Business Overview
12.1.2. Company Snapshot
12.1.3. Company Market Share Analysis
12.1.4. Company Product Portfolio
12.1.5. Recent Developments
12.1.6. SWOT Analysis
12.2. Bayer AG
12.2.1. Business Overview
12.2.2. Company Snapshot
12.2.3. Company Market Share Analysis
12.2.4. Company Product Portfolio
12.2.5. Recent Developments
12.2.6. SWOT Analysis
12.3. Beckman Coulter Inc.
12.3.1. Business Overview
12.3.2. Company Snapshot
12.3.3. Company Market Share Analysis
12.3.4. Company Product Portfolio
12.3.5. Recent Developments
12.3.6. SWOT Analysis
12.4. bioMérieux SA
12.4.1. Business Overview
12.4.2. Company Snapshot
12.4.3. Company Market Share Analysis
12.4.4. Company Product Portfolio
12.4.5. Recent Developments
12.4.6. SWOT Analysis
12.5. Bio-Rad Laboratories
12.5.1. Business Overview
12.5.2. Company Snapshot
12.5.3. Company Market Share Analysis
12.5.4. Company Product Portfolio
12.5.5. Recent Developments
12.5.6. SWOT Analysis
12.6. Danaher Corporation
12.6.1. Business Overview
12.6.2. Company Snapshot
12.6.3. Company Market Share Analysis
12.6.4. Company Product Portfolio
12.6.5. Recent Developments
12.6.6. SWOT Analysis
12.7. Exagen Inc.
12.7.1. Business Overview
12.7.2. Company Snapshot
12.7.3. Company Market Share Analysis
12.7.4. Company Product Portfolio
12.7.5. Recent Developments
12.7.6. SWOT Analysis
12.8. F Hoffmann-La Roche Ltd.
12.8.1. Business Overview
12.8.2. Company Snapshot
12.8.3. Company Market Share Analysis
12.8.4. Company Product Portfolio
12.8.5. Recent Developments
12.8.6. SWOT Analysis
12.9. Siemens Healthineers AG
12.9.1. Business Overview
12.9.2. Company Snapshot
12.9.3. Company Market Share Analysis
12.9.4. Company Product Portfolio
12.9.5. Recent Developments
12.9.6. SWOT Analysis
12.10. Thermo Fisher Scientific
12.10.1. Business Overview
12.10.2. Company Snapshot
12.10.3. Company Market Share Analysis
12.10.4. Company Product Portfolio
12.10.5. Recent Developments
12.10.6. SWOT Analysis
List of Table
1. Global Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
2. Global Equipment Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
3. Global Consumables Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
4. Global Others Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
5. Global Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
6. Global Spectrometry Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
7. Global Electrophoresis Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
8. Global Chromatography Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
9. Global Proteomic Technology Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
10. Global Immunoassays Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
11. Global Others Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
12. Global Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
13. Global Antibiotics Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
14. Global Antiarrhythmic Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
15. Global Bronchodilators Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
16. Global HIV/AIDS Drugs Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
17. Global Antineoplastics Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
18. Global Immunosuppressive Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
19. Global Antiepileptic Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
20. Global Others Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
21. Global Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
22. Global Hospitals Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
23. Global Research and Academic Institutes Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
24. Global Diagnostic Labs Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
25. Global Others Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
26. Global Therapeutic Drug Monitoring Market, By Region, 2019-2032 (USD Billion)
27. North America Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
28. North America Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
29. North America Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
30. North America Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
31. U.S. Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
32. U.S. Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
33. U.S. Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
34. U.S. Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
35. Canada Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
36. Canada Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
37. Canada Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
38. Canada Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
39. Mexico Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
40. Mexico Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
41. Mexico Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
42. Mexico Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
43. Europe Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
44. Europe Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
45. Europe Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
46. Europe Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
47. Germany Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
48. Germany Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
49. Germany Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
50. Germany Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
51. France Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
52. France Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
53. France Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
54. France Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
55. U.K. Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
56. U.K. Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
57. U.K. Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
58. U.K. Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
59. Italy Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
60. Italy Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
61. Italy Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
62. Italy Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
63. Spain Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
64. Spain Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
65. Spain Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
66. Spain Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
67. Asia Pacific Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
68. Asia Pacific Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
69. Asia Pacific Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
70. Asia Pacific Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
71. Japan Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
72. Japan Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
73. Japan Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
74. Japan Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
75. China Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
76. China Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
77. China Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
78. China Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
79. India Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
80. India Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
81. India Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
82. India Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
83. South America Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
84. South America Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
85. South America Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
86. South America Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
87. Brazil Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
88. Brazil Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
89. Brazil Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
90. Brazil Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
91. Middle East and Africa Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
92. Middle East and Africa Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
93. Middle East and Africa Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
94. Middle East and Africa Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
95. UAE Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
96. UAE Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
97. UAE Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
98. UAE Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
99. South Africa Therapeutic Drug Monitoring Market, By Product Type, 2019-2032 (USD Billion)
100. South Africa Therapeutic Drug Monitoring Market, By Technology, 2019-2032 (USD Billion)
101. South Africa Therapeutic Drug Monitoring Market, By Drug Class, 2019-2032 (USD Billion)
102. South Africa Therapeutic Drug Monitoring Market, By End User, 2019-2032 (USD Billion)
List of Figures
1. Global Therapeutic Drug Monitoring Market Segmentation
2. Therapeutic Drug Monitoring Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Therapeutic Drug Monitoring Market Attractiveness Analysis by Product Type
9. Global Therapeutic Drug Monitoring Market Attractiveness Analysis by Technology
10. Global Therapeutic Drug Monitoring Market Attractiveness Analysis by Drug Class
11. Global Therapeutic Drug Monitoring Market Attractiveness Analysis by End User
12. Global Therapeutic Drug Monitoring Market Attractiveness Analysis by Region
13. Global Therapeutic Drug Monitoring Market: Dynamics
14. Global Therapeutic Drug Monitoring Market Share by Product Type (2022 & 2032)
15. Global Therapeutic Drug Monitoring Market Share by Technology (2022 & 2032)
16. Global Therapeutic Drug Monitoring Market Share by Drug Class (2022 & 2032)
17. Global Therapeutic Drug Monitoring Market Share by End User (2022 & 2032)
18. Global Therapeutic Drug Monitoring Market Share by Regions (2022 & 2032)
19. Global Therapeutic Drug Monitoring Market Share by Company (2022)
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global therapeutic drug monitoring market based on below mentioned segments:
Global Therapeutic Drug Monitoring Market by Product Type:
Global Therapeutic Drug Monitoring Market by Technology:
Global Therapeutic Drug Monitoring Market by Drug Class:
Global Therapeutic Drug Monitoring Market by End User:
Global Therapeutic Drug Monitoring Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date
